Gabriele S. De Vos
Professor
Division of Allergy & Immunology, Albert Einstein College of
Yeshiva University
United States of America
Biography
Dr. Gabriele S. de Vos is affiliated to Division of Allergy & Immunology, Albert Einstein College of Medicine , Yeshiva University, where Dr. Gabriele S. de Vos is currently working as Professor. Dr. Gabriele S. de Vos has authored and co-authored several national and international publications and also working as a reviewer for reputed professional journals. Dr. Gabriele S. de Vos is having an active association with different societies and academies around the world. Dr. Gabriele S. de Vos made his mark in the scientific community with the contributions and widely recognition from honourable subject experts around the world. Dr. Gabriele S. de Vos has received several awards for the contributions to the scientific community. Dr. Gabriele S. de Vos major research interest involves Dr. de Vos' research focuses on the pathogenesis of allergic diseases and the induction of immune tolerance by allergen vaccination (immunotherapy). She was awarded the 2008 Young Investigator Award from the American College of Allergy, Asthma and Immunology and received the Career Development Award from the Institute of Clinical and Translational Research of Einstein after completion of the Clinical Research Training Program (CRTP) in 2009. Her publications include original articles and textbook contributions on the diagnostic evaluation of hypersensitivity disorders and desensitization through allergy immunotherapy..
Research Interest
Dr. de Vos' research focuses on the pathogenesis of allergic diseases and the induction of immune tolerance by allergen vaccination (immunotherapy). She was awarded the 2008 Young Investigator Award from the American College of Allergy, Asthma and Immunology and received the Career Development Award from the Institute of Clinical and Translational Research of Einstein after completion of the Clinical Research Training Program (CRTP) in 2009. Her publications include original articles and textbook contributions on the diagnostic evaluation of hypersensitivity disorders and desensitization through allergy immunotherapy.
Publications
-
Collins J, de Vos G, Hudes G, Rosenstreich D (2012) Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab. J Asthma Allergy 5: 65-70.
-
de Vos G, Nazari R, Ferastraoaru D, Parikh P, Geliebter R (2013)Discordance between aeroallergen specific serum IgE and skin testing in children younger than 4 years. Ann Allergy Asthma Immunol 110: 438-443.
